Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-11-30

FDA Approved: DOFETILIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application from Aurobindo Pharma Limited to manufacture and market dofetilide as a generic drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dofetilide (dofetilide)

Snippet

SUPPL AP for DOFETILIDE (DOFETILIDE)